董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Neal Goldman | 男 | Independent Director and Vice Chairman of the Board | 81 | 12.00万美元 | 未持股 | 2025-12-18 |
| Benedetta Casamento | 女 | Chairman of the Board and Independent Director | 55 | 12.00万美元 | 未持股 | 2025-12-18 |
| Eric Hines | 男 | Chief Executive Officer,Director and President | 58 | 未披露 | 未持股 | 2025-12-18 |
| Didier Demesmin | 男 | Director | 56 | 10.00万美元 | 未持股 | 2025-12-18 |
| Shanth Thiyagalingam | 男 | Director | 44 | 未披露 | 未持股 | 2025-12-18 |
| Dawood Sayed | 男 | Director | 46 | 未披露 | 未持股 | 2025-12-18 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Eric Hines | 男 | Chief Executive Officer,Director and President | 58 | 未披露 | 未持股 | 2025-12-18 |
董事简历
中英对照 | 中文 | 英文- Neal Goldman
-
Neal Goldman是高盛资本管理公司（Goldman Capital Management，Inc.）的总裁兼创始人，该公司自2018年以来一直是家族企业，此前是一家成立于1985年的投资咨询公司。他是Shearson Lehman Hutton的第一位研究Vice President。他也曾担任多种公司的高级职务，包括Neuberger Berman公司、Moseley Hallgarten Estabrook and Weeden公司、Bruns Nordeman公司、Russ and Company的货币经理兼研究分析师。Goldman先生自2016年起担任Charles&Colvard，Ltd.董事长，并担任Imageware Systems，Inc.的董事会成员。他也任职于Deep-Down Inc.的董事会。DPDW。在他们被收购之前，他曾在Blyth Industries和iPass Corporation的董事会任职。Goldman先生是特许金融分析师（CFA）。他也任职于众多非营利董事会。Goldman先生在纽约城市大学（City College）获得经济学学士学位。
Neal Goldman has been a director of Milestone Scientific since 2019 and has served as Chairman of the Board since January 2024. Mr. Goldman is the President and Founder of Goldman Capital Management, Inc., a family office since 2018, which was previoly an investment advisory firm founded in 1985. He was First Vice President of Research at Shearson Lehman Hutton. He has also held senior positions as a money manager and research analyst with a variety of firms including Neuberger Berman, Moseley Hallgarten Estabrook and eden, Bruns Nordeman, and Rs and Company. Mr. Goldman serves as Chairman of Charles & Colvard, Ltd. since 2016 and served on the board of Imageware Systems, Inc. until November 2020. He also serves on the board of Deep Down Inc. Prior to their respective acquisitions, he served on the boards of Blyth Indtries and IPASS Corporation. Mr. Goldman received his B.A. degree in Economics from The City University of New York (City College). - Neal Goldman是高盛资本管理公司（Goldman Capital Management，Inc.）的总裁兼创始人，该公司自2018年以来一直是家族企业，此前是一家成立于1985年的投资咨询公司。他是Shearson Lehman Hutton的第一位研究Vice President。他也曾担任多种公司的高级职务，包括Neuberger Berman公司、Moseley Hallgarten Estabrook and Weeden公司、Bruns Nordeman公司、Russ and Company的货币经理兼研究分析师。Goldman先生自2016年起担任Charles&Colvard，Ltd.董事长，并担任Imageware Systems，Inc.的董事会成员。他也任职于Deep-Down Inc.的董事会。DPDW。在他们被收购之前，他曾在Blyth Industries和iPass Corporation的董事会任职。Goldman先生是特许金融分析师（CFA）。他也任职于众多非营利董事会。Goldman先生在纽约城市大学（City College）获得经济学学士学位。
- Neal Goldman has been a director of Milestone Scientific since 2019 and has served as Chairman of the Board since January 2024. Mr. Goldman is the President and Founder of Goldman Capital Management, Inc., a family office since 2018, which was previoly an investment advisory firm founded in 1985. He was First Vice President of Research at Shearson Lehman Hutton. He has also held senior positions as a money manager and research analyst with a variety of firms including Neuberger Berman, Moseley Hallgarten Estabrook and eden, Bruns Nordeman, and Rs and Company. Mr. Goldman serves as Chairman of Charles & Colvard, Ltd. since 2016 and served on the board of Imageware Systems, Inc. until November 2020. He also serves on the board of Deep Down Inc. Prior to their respective acquisitions, he served on the boards of Blyth Indtries and IPASS Corporation. Mr. Goldman received his B.A. degree in Economics from The City University of New York (City College).
- Benedetta Casamento
-
Benedetta Casamento，自2022年4月起担任公司董事。自2017年8月起，Casamento女士担任零售顾问，专门从事财务、业务运营以及财务规划和分析。Casamento女士此前曾于2016年6月至2017年8月担任Allyke，Inc.的董事长兼总裁，Allyke，Inc.是一家为零售和其他行业创造数字图像洞察的人工智能公司。2014年12月至2016年4月，她担任女性服饰和配饰奢侈精品零售商Calypso St. Barth的首席执行官。在担任Calypso St. Barth首席执行官之前，Casamento女士曾在2012年7月至2014年12月期间担任零售和时尚领域投资组合兴趣的私募股权公司的顾问。Casamento女士此前曾于2009年3月至2012年7月担任陶伯专卖店（“Talbots”）的财务与运营执行副总裁，该公司是一家女性服装、配饰和鞋子的专业零售商和直销商。在加入Talbots之前，Casamento女士曾于1999年2月至2008年11月在Liz Claiborne Inc.担任多个领导职务，最终担任Liz Claiborne Brands总裁。卡萨门托女士的职业生涯始于萨克斯第五大道。
Benedetta Casamento has served as a director of the Company since April 2022. Since Augt 2017, Ms. Casamento has served as a consultant and a board member specializing in strategy, finance, and operations. Ms. Casamento previoly served as Chairman and President of Allyke, Inc., an artificial intelligence company creating digital imagery insights for retail and other indtries, from June 2016 to Augt 2017. From December 2014 to April 2016, she served as Chief Executive Officer of Calypso St. Barth, a luxury boutique retailer of women's apparel and accessories. Prior to her role as CEO at Calypso St. Barth, Ms. Casamento served as a consultant to private equity firms with portfolio interests in retail and fashion from July 2012 to December 2014. Ms. Casamento previoly served as Executive Vice President, Finance & Operations of The Talbots, Inc. ("Talbots"), a specialty retailer and direct marketer of women's apparel, accessories, and shoes, from March 2009 to July 2012. Prior to joining Talbots, Ms. Casamento served in vario leadership roles within Liz Claiborne Inc. from February 1999 to November 2008, culminating in her position as President of Liz Claiborne Brands. Ms. Casamento started her career at Saks Fifth Avenue. - Benedetta Casamento，自2022年4月起担任公司董事。自2017年8月起，Casamento女士担任零售顾问，专门从事财务、业务运营以及财务规划和分析。Casamento女士此前曾于2016年6月至2017年8月担任Allyke，Inc.的董事长兼总裁，Allyke，Inc.是一家为零售和其他行业创造数字图像洞察的人工智能公司。2014年12月至2016年4月，她担任女性服饰和配饰奢侈精品零售商Calypso St. Barth的首席执行官。在担任Calypso St. Barth首席执行官之前，Casamento女士曾在2012年7月至2014年12月期间担任零售和时尚领域投资组合兴趣的私募股权公司的顾问。Casamento女士此前曾于2009年3月至2012年7月担任陶伯专卖店（“Talbots”）的财务与运营执行副总裁，该公司是一家女性服装、配饰和鞋子的专业零售商和直销商。在加入Talbots之前，Casamento女士曾于1999年2月至2008年11月在Liz Claiborne Inc.担任多个领导职务，最终担任Liz Claiborne Brands总裁。卡萨门托女士的职业生涯始于萨克斯第五大道。
- Benedetta Casamento has served as a director of the Company since April 2022. Since Augt 2017, Ms. Casamento has served as a consultant and a board member specializing in strategy, finance, and operations. Ms. Casamento previoly served as Chairman and President of Allyke, Inc., an artificial intelligence company creating digital imagery insights for retail and other indtries, from June 2016 to Augt 2017. From December 2014 to April 2016, she served as Chief Executive Officer of Calypso St. Barth, a luxury boutique retailer of women's apparel and accessories. Prior to her role as CEO at Calypso St. Barth, Ms. Casamento served as a consultant to private equity firms with portfolio interests in retail and fashion from July 2012 to December 2014. Ms. Casamento previoly served as Executive Vice President, Finance & Operations of The Talbots, Inc. ("Talbots"), a specialty retailer and direct marketer of women's apparel, accessories, and shoes, from March 2009 to July 2012. Prior to joining Talbots, Ms. Casamento served in vario leadership roles within Liz Claiborne Inc. from February 1999 to November 2008, culminating in her position as President of Liz Claiborne Brands. Ms. Casamento started her career at Saks Fifth Avenue.
- Eric Hines
-
Eric Hines，最近在EX Libris Group（2014年9月-2021年6月）担任北美总裁，EX Libris Group是一家为高等教育和图书馆提供基于云的解决方案的全球供应商。从2021年6月到2025年7月，海因斯先生参与为科技初创公司Alethea提供咨询服务，还投资了商业和个人房地产企业。在EX Libris Group任职之前，Hines先生曾在NICE Systems（2004年10月-2014年6月）担任过多个职务，这是一家设计和制造智能家居安全和自动化产品的跨国公司。Hines先生于2004年10月至2005年11月担任NICE Systems的高级销售总监，随后于2005年11月至2014年6月担任NICE Systems多个北美部门的副总裁。在此之前，Hines先生曾担任AMDOCS Clarify CRM（2003年10月-2004年10月）的区域销售总监，该公司是一家为通信行业提供客户关系管理（CRM）解决方案的供应商。海因斯1989年获得维克森林大学化学学士学位，1996年获得泽维尔大学国际商务MBA学位。
Eric Hines has been President, Chief Executive Officer and a director of Milestone Scientific since July 31, 2025. He most recently served as President of North America at Ex Libris Group (September 2014 June 2021), a global provider of cloud based solutions for higher education and libraries. From June 2021 to July 2025, Mr. Hines was involved in providing consulting services for Alethea, a technology start up company, and also invested in commercial and personal real estate ventures. Prior to his role at Ex Libris Group, Mr. Hines held vario roles at NICE Systems (October 2004 June 2014), a multinational company that designs and manufactures smart home security and automation products. Mr. Hines served as Senior Director of Sales at NICE Systems from October 2004 to November 2005 and subsequently served as Vice President of several North American divisions of NICE Systems from November 2005 through June 2014. Prior thereto, Mr. Hines served as Regional Director of Sales at AMDOCS Clarify CRM (October 2003 October 2004), a provider of ctomer relationship management (CRM) solutions to the communications indtry. Mr. Hines received a Bachelor of Science in Chemistry from Wake Forest University in 1989 and an MBA in International Biness from Xavier University in 1996. - Eric Hines，最近在EX Libris Group（2014年9月-2021年6月）担任北美总裁，EX Libris Group是一家为高等教育和图书馆提供基于云的解决方案的全球供应商。从2021年6月到2025年7月，海因斯先生参与为科技初创公司Alethea提供咨询服务，还投资了商业和个人房地产企业。在EX Libris Group任职之前，Hines先生曾在NICE Systems（2004年10月-2014年6月）担任过多个职务，这是一家设计和制造智能家居安全和自动化产品的跨国公司。Hines先生于2004年10月至2005年11月担任NICE Systems的高级销售总监，随后于2005年11月至2014年6月担任NICE Systems多个北美部门的副总裁。在此之前，Hines先生曾担任AMDOCS Clarify CRM（2003年10月-2004年10月）的区域销售总监，该公司是一家为通信行业提供客户关系管理（CRM）解决方案的供应商。海因斯1989年获得维克森林大学化学学士学位，1996年获得泽维尔大学国际商务MBA学位。
- Eric Hines has been President, Chief Executive Officer and a director of Milestone Scientific since July 31, 2025. He most recently served as President of North America at Ex Libris Group (September 2014 June 2021), a global provider of cloud based solutions for higher education and libraries. From June 2021 to July 2025, Mr. Hines was involved in providing consulting services for Alethea, a technology start up company, and also invested in commercial and personal real estate ventures. Prior to his role at Ex Libris Group, Mr. Hines held vario roles at NICE Systems (October 2004 June 2014), a multinational company that designs and manufactures smart home security and automation products. Mr. Hines served as Senior Director of Sales at NICE Systems from October 2004 to November 2005 and subsequently served as Vice President of several North American divisions of NICE Systems from November 2005 through June 2014. Prior thereto, Mr. Hines served as Regional Director of Sales at AMDOCS Clarify CRM (October 2003 October 2004), a provider of ctomer relationship management (CRM) solutions to the communications indtry. Mr. Hines received a Bachelor of Science in Chemistry from Wake Forest University in 1989 and an MBA in International Biness from Xavier University in 1996.
- Didier Demesmin
-
Didier Demesmin自2024年起担任里程碑科技的董事。他目前是大学疼痛医学中心的首席执行官和医学主任，他从2007年开始担任该职位。自2006年3月起，Demesmin博士担任圣彼得大学医院疼痛管理科主任。他还是肯尼迪医疗中心（自2007年3月起）、罗伯特伍德约翰逊大学医院（自2008年1月起）、萨默塞特医疗中心（自2009年2月起）、哈德逊地区医院（自2010年12月起）、圣巴纳巴斯医院（自2013年11月起）疼痛医学科的医师。Demesmin博士还是罗格斯大学罗伯特伍德约翰逊医学院医学系的临床讲师（自2006年8月起）、罗格斯大学罗伯特伍德约翰逊医学院物理医学和康复系的临床助理教授（自2013年7月起）、圣彼得大学医院物理医学和康复与运动医学研究所的医学主任（自（2013年12月起），以及肯尼迪约翰逊康复研究所多学科介入疼痛医学研究金的助理研究金项目主任（自2013年11月起）。Demesmin博士自2010年9月起担任新泽西州介入疼痛医师协会Trtees委员会成员，自2010年1月起担任新泽西州米德尔塞克斯县医疗协会成员，2011年6月至2012年6月担任当选主席职务，2012年6月至2014年6月担任主席职务。Demesmin博士于1994年获得罗格斯大学心理学学士学位，2000年获得新泽西州医学和牙科大学医学学位，2018年获得诺斯滕大学家乐氏管理学院MBA学位。
Didier Demesmin has been a director of Milestone Scientific since 2024. He is currently the Chief Executive Officer and Medical Director of University Pain Medicine Center, a position he has held since 2007. Since March 2006, Dr. Demesmin has held the position of Director of the Pain Management Department at St. Peter's University Hospital. He is also a physician in the Departments of Pain Medicine at JFK Medical Center (since March 2007), Robert Wood Johnson University Hospital (since January 2008), Somerset Medical Center (since February 2009), Hudson Regional Hospital (since December 2010), and Saint Barnabas Hospital (since November 2013). Dr. Demesmin is also a Clinical Instructor in the Department of Medicine at Rutgers Robert Wood Johnson Medical School (since Augt 2006), a Clinical Assistant Professor in the Department of Physical Medicine and Rehabilitation at Rutgers Robert Wood Johnson Medical School (since July 2013), the Medical Director in the Physical Medicine and Rehabilitation and Sports Medicine Institute at St. Peter's University Hospital (since December 2013), and an Assistant Fellowship Program Director in the Multidisciplinary Interventional Pain Medicine Fellowship at JFK Johnson Rehabilitation Institute (since November 2013). Dr. Demesmin has been a member of the Board of Trtees of the New Jersey Society of Interventional Pain Physicians, since September 2010, and the Middlesex County Medical Society of New Jersey, since January 2010, where he held the positions of President Elect, from June 2011 to June 2012, and President, from June 2012 to June 2014. Dr. Demesmin received a BA in Psychology from Rutgers University in 1994, a Medical Degree from the University of Medicine and Dentistry of New Jersey in 2000, and an MBA from the Kellogg School of Management of Northstern University in 2018. - Didier Demesmin自2024年起担任里程碑科技的董事。他目前是大学疼痛医学中心的首席执行官和医学主任，他从2007年开始担任该职位。自2006年3月起，Demesmin博士担任圣彼得大学医院疼痛管理科主任。他还是肯尼迪医疗中心（自2007年3月起）、罗伯特伍德约翰逊大学医院（自2008年1月起）、萨默塞特医疗中心（自2009年2月起）、哈德逊地区医院（自2010年12月起）、圣巴纳巴斯医院（自2013年11月起）疼痛医学科的医师。Demesmin博士还是罗格斯大学罗伯特伍德约翰逊医学院医学系的临床讲师（自2006年8月起）、罗格斯大学罗伯特伍德约翰逊医学院物理医学和康复系的临床助理教授（自2013年7月起）、圣彼得大学医院物理医学和康复与运动医学研究所的医学主任（自（2013年12月起），以及肯尼迪约翰逊康复研究所多学科介入疼痛医学研究金的助理研究金项目主任（自2013年11月起）。Demesmin博士自2010年9月起担任新泽西州介入疼痛医师协会Trtees委员会成员，自2010年1月起担任新泽西州米德尔塞克斯县医疗协会成员，2011年6月至2012年6月担任当选主席职务，2012年6月至2014年6月担任主席职务。Demesmin博士于1994年获得罗格斯大学心理学学士学位，2000年获得新泽西州医学和牙科大学医学学位，2018年获得诺斯滕大学家乐氏管理学院MBA学位。
- Didier Demesmin has been a director of Milestone Scientific since 2024. He is currently the Chief Executive Officer and Medical Director of University Pain Medicine Center, a position he has held since 2007. Since March 2006, Dr. Demesmin has held the position of Director of the Pain Management Department at St. Peter's University Hospital. He is also a physician in the Departments of Pain Medicine at JFK Medical Center (since March 2007), Robert Wood Johnson University Hospital (since January 2008), Somerset Medical Center (since February 2009), Hudson Regional Hospital (since December 2010), and Saint Barnabas Hospital (since November 2013). Dr. Demesmin is also a Clinical Instructor in the Department of Medicine at Rutgers Robert Wood Johnson Medical School (since Augt 2006), a Clinical Assistant Professor in the Department of Physical Medicine and Rehabilitation at Rutgers Robert Wood Johnson Medical School (since July 2013), the Medical Director in the Physical Medicine and Rehabilitation and Sports Medicine Institute at St. Peter's University Hospital (since December 2013), and an Assistant Fellowship Program Director in the Multidisciplinary Interventional Pain Medicine Fellowship at JFK Johnson Rehabilitation Institute (since November 2013). Dr. Demesmin has been a member of the Board of Trtees of the New Jersey Society of Interventional Pain Physicians, since September 2010, and the Middlesex County Medical Society of New Jersey, since January 2010, where he held the positions of President Elect, from June 2011 to June 2012, and President, from June 2012 to June 2014. Dr. Demesmin received a BA in Psychology from Rutgers University in 1994, a Medical Degree from the University of Medicine and Dentistry of New Jersey in 2000, and an MBA from the Kellogg School of Management of Northstern University in 2018.
- Shanth Thiyagalingam
-
Shanth Thiyagalingam自2025年起担任里程碑科技的董事。他目前担任PainTEQ的首席执行官，PainTEQ是一家专注于介入疼痛治疗的专有医疗设备制造商。从2020年到2025年，他在公司连续担任领导职务——从首席商务官到首席运营官，最终担任首席执行官。在任期间，他带领公司从早期创业公司转型为介入疼痛领域的超成长创新者。他还领导了并购计划，并在确保LinQ程序的1类CPT代码方面发挥了重要作用——这是介入疼痛市场的一种新疗法。在他的领导下，PainTEQ连续三年获得INC 5000的认可，并被坦帕湾Biness JNal评为“最佳工作场所”。他拥有悉尼大学医学学士学位、市场营销管理硕士学位、麦格理管理研究生院（MGSM）MBA学位。他还是盖洛普实力认证教练，热衷于培养高绩效文化和指导医疗技术行业的新兴领导者。
Shanth Thiyagalingam has been a director of Milestone Scientific since 2025. He currently serves as Chief Executive Officer of PainTEQ, a manufacturer of proprietary medical equipment foced on interventional pain therapy. From 2020 through 2025, he held successive leadership roles at the company—from Chief Commercial Officer to Chief Operating Officer, and ultimately as CEO. During his tenure, he led the company's transformation from early stage startup to hyper growth innovator in the interventional pain space. He also led M&A initiatives and was instrumental in securing a Category 1 CPT code for the LinQ procedure—a new therapy in the interventional pain market. Under his leadership, PainTEQ was recognized three years in a row by the INC 5000 and named a "Best Place to Work" by the Tampa Bay Biness Jnal. He holds a Bachelor of Medical Science from the University of Sydney, a Master's in Marketing Management, and an MBA from Macquarie Graduate School of Management (MGSM). He is also a certified Gallup Strengths Coach and is passionate about fostering high performance cultures and mentoring emerging leaders in the medtech indtry. - Shanth Thiyagalingam自2025年起担任里程碑科技的董事。他目前担任PainTEQ的首席执行官，PainTEQ是一家专注于介入疼痛治疗的专有医疗设备制造商。从2020年到2025年，他在公司连续担任领导职务——从首席商务官到首席运营官，最终担任首席执行官。在任期间，他带领公司从早期创业公司转型为介入疼痛领域的超成长创新者。他还领导了并购计划，并在确保LinQ程序的1类CPT代码方面发挥了重要作用——这是介入疼痛市场的一种新疗法。在他的领导下，PainTEQ连续三年获得INC 5000的认可，并被坦帕湾Biness JNal评为“最佳工作场所”。他拥有悉尼大学医学学士学位、市场营销管理硕士学位、麦格理管理研究生院（MGSM）MBA学位。他还是盖洛普实力认证教练，热衷于培养高绩效文化和指导医疗技术行业的新兴领导者。
- Shanth Thiyagalingam has been a director of Milestone Scientific since 2025. He currently serves as Chief Executive Officer of PainTEQ, a manufacturer of proprietary medical equipment foced on interventional pain therapy. From 2020 through 2025, he held successive leadership roles at the company—from Chief Commercial Officer to Chief Operating Officer, and ultimately as CEO. During his tenure, he led the company's transformation from early stage startup to hyper growth innovator in the interventional pain space. He also led M&A initiatives and was instrumental in securing a Category 1 CPT code for the LinQ procedure—a new therapy in the interventional pain market. Under his leadership, PainTEQ was recognized three years in a row by the INC 5000 and named a "Best Place to Work" by the Tampa Bay Biness Jnal. He holds a Bachelor of Medical Science from the University of Sydney, a Master's in Marketing Management, and an MBA from Macquarie Graduate School of Management (MGSM). He is also a certified Gallup Strengths Coach and is passionate about fostering high performance cultures and mentoring emerging leaders in the medtech indtry.
- Dawood Sayed
-
Dawood Sayed是堪萨斯大学医学中心麻醉学和疼痛医学教授，目前担任疼痛医学部门主管、介入脊柱服务主任和神经调节中心主任。凭借robt临床、学术和政策背景，他在开创微创疼痛疗法、神经调节和卫生系统创新方面带来了十多年的领导力。Sayed博士还担任美国疼痛与神经科学协会（ASPN）的副主席和联合创始人，在那里他与主要利益相关者密切合作，包括商业付款人、监管机构和医疗设备制造商，以推动获得创新的疼痛缓解技术。他的领导能力为他赢得了多项荣誉，包括北美神经调节学会（NANS）颁发的2025年总统奖。Sayed博士撰写了100多篇同行审查的出版物，为疼痛医学的国家指南做出了贡献，目前领导了多项评估神经调节和脊柱疗法的临床试验。他还担任几位领先的医疗技术创新者的医疗顾问，并参加国家AMA CPT和NANS倡导委员会。
Dawood Sayed is a Profssor of Anesthesiology and Pain Medicine at the University of Kansas Medical Center and currently serves as Division Chief of Pain Medicine, Director of Interventional Spine Services, and Director of the Center for Neuromodulation. With a robt clinical, academic, and policy background, he hass over a decade of leadership in pioneering minimally invasive pain therapies, neuromodulation, and health system innovation. Dr. Sayed also serves as Vice Chairman and Co Founder of the American Society of Pain and Neuroscience (ASPN), where he works closely with key stakeholders, including commercial payers, regulators, and medical device manufacturers to advance access to innovative pain relief technologies. His leadership has earned him multiple honors, including the 2025 Presidential Award from the North American Neuromodulation Society (NANS). Dr. Sayed has authored over 100 peer revied publications, contributed to national guidelines in pain medicine, and currently leads multiple clinical trials evaluating neuromodulation and spinal therapies. He also serves as a medical advisor to several leading medtech innovators and participates on national AMA CPT and NANS advocacy committees. - Dawood Sayed是堪萨斯大学医学中心麻醉学和疼痛医学教授，目前担任疼痛医学部门主管、介入脊柱服务主任和神经调节中心主任。凭借robt临床、学术和政策背景，他在开创微创疼痛疗法、神经调节和卫生系统创新方面带来了十多年的领导力。Sayed博士还担任美国疼痛与神经科学协会（ASPN）的副主席和联合创始人，在那里他与主要利益相关者密切合作，包括商业付款人、监管机构和医疗设备制造商，以推动获得创新的疼痛缓解技术。他的领导能力为他赢得了多项荣誉，包括北美神经调节学会（NANS）颁发的2025年总统奖。Sayed博士撰写了100多篇同行审查的出版物，为疼痛医学的国家指南做出了贡献，目前领导了多项评估神经调节和脊柱疗法的临床试验。他还担任几位领先的医疗技术创新者的医疗顾问，并参加国家AMA CPT和NANS倡导委员会。
- Dawood Sayed is a Profssor of Anesthesiology and Pain Medicine at the University of Kansas Medical Center and currently serves as Division Chief of Pain Medicine, Director of Interventional Spine Services, and Director of the Center for Neuromodulation. With a robt clinical, academic, and policy background, he hass over a decade of leadership in pioneering minimally invasive pain therapies, neuromodulation, and health system innovation. Dr. Sayed also serves as Vice Chairman and Co Founder of the American Society of Pain and Neuroscience (ASPN), where he works closely with key stakeholders, including commercial payers, regulators, and medical device manufacturers to advance access to innovative pain relief technologies. His leadership has earned him multiple honors, including the 2025 Presidential Award from the North American Neuromodulation Society (NANS). Dr. Sayed has authored over 100 peer revied publications, contributed to national guidelines in pain medicine, and currently leads multiple clinical trials evaluating neuromodulation and spinal therapies. He also serves as a medical advisor to several leading medtech innovators and participates on national AMA CPT and NANS advocacy committees.
高管简历
中英对照 | 中文 | 英文- Eric Hines
Eric Hines，最近在EX Libris Group（2014年9月-2021年6月）担任北美总裁，EX Libris Group是一家为高等教育和图书馆提供基于云的解决方案的全球供应商。从2021年6月到2025年7月，海因斯先生参与为科技初创公司Alethea提供咨询服务，还投资了商业和个人房地产企业。在EX Libris Group任职之前，Hines先生曾在NICE Systems（2004年10月-2014年6月）担任过多个职务，这是一家设计和制造智能家居安全和自动化产品的跨国公司。Hines先生于2004年10月至2005年11月担任NICE Systems的高级销售总监，随后于2005年11月至2014年6月担任NICE Systems多个北美部门的副总裁。在此之前，Hines先生曾担任AMDOCS Clarify CRM（2003年10月-2004年10月）的区域销售总监，该公司是一家为通信行业提供客户关系管理（CRM）解决方案的供应商。海因斯1989年获得维克森林大学化学学士学位，1996年获得泽维尔大学国际商务MBA学位。
Eric Hines has been President, Chief Executive Officer and a director of Milestone Scientific since July 31, 2025. He most recently served as President of North America at Ex Libris Group (September 2014 June 2021), a global provider of cloud based solutions for higher education and libraries. From June 2021 to July 2025, Mr. Hines was involved in providing consulting services for Alethea, a technology start up company, and also invested in commercial and personal real estate ventures. Prior to his role at Ex Libris Group, Mr. Hines held vario roles at NICE Systems (October 2004 June 2014), a multinational company that designs and manufactures smart home security and automation products. Mr. Hines served as Senior Director of Sales at NICE Systems from October 2004 to November 2005 and subsequently served as Vice President of several North American divisions of NICE Systems from November 2005 through June 2014. Prior thereto, Mr. Hines served as Regional Director of Sales at AMDOCS Clarify CRM (October 2003 October 2004), a provider of ctomer relationship management (CRM) solutions to the communications indtry. Mr. Hines received a Bachelor of Science in Chemistry from Wake Forest University in 1989 and an MBA in International Biness from Xavier University in 1996.- Eric Hines，最近在EX Libris Group（2014年9月-2021年6月）担任北美总裁，EX Libris Group是一家为高等教育和图书馆提供基于云的解决方案的全球供应商。从2021年6月到2025年7月，海因斯先生参与为科技初创公司Alethea提供咨询服务，还投资了商业和个人房地产企业。在EX Libris Group任职之前，Hines先生曾在NICE Systems（2004年10月-2014年6月）担任过多个职务，这是一家设计和制造智能家居安全和自动化产品的跨国公司。Hines先生于2004年10月至2005年11月担任NICE Systems的高级销售总监，随后于2005年11月至2014年6月担任NICE Systems多个北美部门的副总裁。在此之前，Hines先生曾担任AMDOCS Clarify CRM（2003年10月-2004年10月）的区域销售总监，该公司是一家为通信行业提供客户关系管理（CRM）解决方案的供应商。海因斯1989年获得维克森林大学化学学士学位，1996年获得泽维尔大学国际商务MBA学位。
- Eric Hines has been President, Chief Executive Officer and a director of Milestone Scientific since July 31, 2025. He most recently served as President of North America at Ex Libris Group (September 2014 June 2021), a global provider of cloud based solutions for higher education and libraries. From June 2021 to July 2025, Mr. Hines was involved in providing consulting services for Alethea, a technology start up company, and also invested in commercial and personal real estate ventures. Prior to his role at Ex Libris Group, Mr. Hines held vario roles at NICE Systems (October 2004 June 2014), a multinational company that designs and manufactures smart home security and automation products. Mr. Hines served as Senior Director of Sales at NICE Systems from October 2004 to November 2005 and subsequently served as Vice President of several North American divisions of NICE Systems from November 2005 through June 2014. Prior thereto, Mr. Hines served as Regional Director of Sales at AMDOCS Clarify CRM (October 2003 October 2004), a provider of ctomer relationship management (CRM) solutions to the communications indtry. Mr. Hines received a Bachelor of Science in Chemistry from Wake Forest University in 1989 and an MBA in International Biness from Xavier University in 1996.